Added to YB: 2019-05-10
Pitch date: 2019-05-10
DVAX [bearish]
Dynavax Technologies Corporation
-102.61%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Dynavax Technologies Corporation, a commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States and internationally.
Market Cap
$1.8B
Pitch Price
$7.65
Price Target
N/A
Dividend
N/A
EV/EBITDA
50.70
P/E
-43.12
EV/Sales
4.25
Sector
Biotechnology
Category
N/A
Show full summary:
DYNAVAX TECHNOLOGIES CORP DVAX
A summary for this pitch has not been created yet.
Read full article (0 min)